» Articles » PMID: 37450554

A New Scoring System with Simple Preoperative Parameters As Predictors of Early Recurrence of Pancreatic Ductal Adenocarcinoma

Abstract

Background: Pancreatic ductal adenocarcinoma (PDAC) often recurs early after radical resection, and such early recurrence (ER) is associated with a poor prognosis. Predicting ER is useful for determining the optimal treatment.

Methods: One hundred fifty-three patients who underwent pancreatectomy for PDAC were divided into an ER group (n = 54) and non-ER group (n = 99). Clinicopathological factors were compared between the groups, and the predictors of ER and prognosis after PDAC resection were examined.

Results: The ER group had a higher platelet count, higher platelet-to-lymphocyte ratio (PLR), higher preoperative CA19-9 concentration, higher SPan-1 concentration, larger tumor diameter, and more lymph node metastasis. The receiver operating characteristic (ROC) curve analysis identified cut-off values for PLR, carbohydrate antigen 19-9 (CA19-9), SPan-1, and tumor diameter. In the multivariate analysis, a high PLR, high CA19-9, and tumor diameter of >3.1 cm were independent predictors of ER after resection (all p < 0.05). When the parameter exceeded the cut-off level, 1 point was given, and the total score of the three factors was defined as the ER prediction score. Next, our new ER prediction model using PLR, CA19-9 and tumor diameter (Logit(p) = 1.6 + 1.2 × high PLR + 0.7 × high CA19-9 + 0.5 × tumor diameter > 3.1cm) distinguished ER with an area under the curve of 0.763, a sensitivity of 85.2%, and a specificity of 55.6%.

Conclusions: ER after resection of PDAC can be predicted by calculation of a score using the preoperative serum CA19-9 concentration, PLR, and tumor diameter.

Citing Articles

Impact of preoperative statin medication on long-term outcomes after pancreatoduodenectomy for ductal adenocarcinoma: an international multicentric cross-sectional study.

Joliat G, Gaspar-Figueiredo S, Labgaa I, Vrochides D, Perinel J, Adham M J Cancer Res Clin Oncol. 2023; 149(19):17007-17014.

PMID: 37740766 PMC: 10657279. DOI: 10.1007/s00432-023-05426-2.


A Retrospective Comparative Evaluation of Selected Blood Cell Ratios, Acute Phase Proteins, and Leukocyte Changes Suggestive of Inflammation in Cats.

Donato G, Pennisi M, Persichetti M, Archer J, Masucci M Animals (Basel). 2023; 13(16).

PMID: 37627371 PMC: 10451877. DOI: 10.3390/ani13162579.

References
1.
Wu Y, Li C, Zhao J, Yang L, Liu F, Zheng H . Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis. World J Surg Oncol. 2016; 14(1):289. PMC: 5112720. DOI: 10.1186/s12957-016-1044-9. View

2.
Teasdale G, Jennett B . Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974; 2(7872):81-4. DOI: 10.1016/s0140-6736(74)91639-0. View

3.
Iguchi T, Iseda N, Hirose K, Itoh S, Harada N, Ninomiya M . Prognostic Impact of the Preoperative Systemic Inflammation Score in Patients With Pancreatic Ductal Adenocarcinoma. Am Surg. 2022; 89(6):2213-2219. DOI: 10.1177/00031348221086782. View

4.
Zhai L, Wu Y, Huang D, Tang Z . Increased matrix metalloproteinase-2 expression and reduced tissue factor pathway inhibitor-2 expression correlate with angiogenesis and early postoperative recurrence of pancreatic carcinoma. Am J Transl Res. 2016; 7(11):2412-22. PMC: 4697719. View

5.
Itoh S, Tsujita E, Fukuzawa K, Sugimachi K, Iguchi T, Ninomiya M . Prognostic significance of preoperative PNI and CA19-9 for pancreatic ductal adenocarcinoma: A multi-institutional retrospective study. Pancreatology. 2021; 21(7):1356-1363. DOI: 10.1016/j.pan.2021.08.003. View